These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

474 related items for PubMed ID: 18536573

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4. Benzodithiophenes induce differentiation and apoptosis in human leukemia cells.
    Jing Y, Hellinger N, Xia L, Monks A, Sausville EA, Zelent A, Waxman S.
    Cancer Res; 2005 Sep 01; 65(17):7847-55. PubMed ID: 16140954
    [Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6. Histone deacetylases: a common molecular target for differentiation treatment of acute myeloid leukemias?
    Minucci S, Nervi C, Lo Coco F, Pelicci PG.
    Oncogene; 2001 May 28; 20(24):3110-5. PubMed ID: 11420727
    [Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. In vivo analysis of the molecular pathogenesis of acute promyelocytic leukemia in the mouse and its therapeutic implications.
    He LZ, Merghoub T, Pandolfi PP.
    Oncogene; 1999 Sep 20; 18(38):5278-92. PubMed ID: 10498880
    [Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. Modeling acute promyelocytic leukemia in the mouse: new insights in the pathogenesis of human leukemias.
    Merghoub T, Gurrieri C, Piazza F, Pandolfi PP.
    Blood Cells Mol Dis; 2001 Sep 20; 27(1):231-48. PubMed ID: 11358384
    [Abstract] [Full Text] [Related]

  • 11. Eradication of acute promyelocytic leukemia-initiating cells through PML-RARA degradation.
    Nasr R, Guillemin MC, Ferhi O, Soilihi H, Peres L, Berthier C, Rousselot P, Robledo-Sarmiento M, Lallemand-Breitenbach V, Gourmel B, Vitoux D, Pandolfi PP, Rochette-Egly C, Zhu J, de Thé H.
    Nat Med; 2008 Dec 20; 14(12):1333-42. PubMed ID: 19029980
    [Abstract] [Full Text] [Related]

  • 12. Molecular signature of retinoic acid treatment in acute promyelocytic leukemia.
    Meani N, Minardi S, Licciulli S, Gelmetti V, Coco FL, Nervi C, Pelicci PG, Müller H, Alcalay M.
    Oncogene; 2005 May 05; 24(20):3358-68. PubMed ID: 15735696
    [Abstract] [Full Text] [Related]

  • 13. The integrity of the charged pocket in the BTB/POZ domain is essential for the phenotype induced by the leukemia-associated t(11;17) fusion protein PLZF/RARalpha.
    Puccetti E, Zheng X, Brambilla D, Seshire A, Beissert T, Boehrer S, Nürnberger H, Hoelzer D, Ottmann OG, Nervi C, Ruthardt M.
    Cancer Res; 2005 Jul 15; 65(14):6080-8. PubMed ID: 16024608
    [Abstract] [Full Text] [Related]

  • 14. Cooperative action of 1alpha,25-dihydroxyvitamin D3 and retinoic acid in NB4 acute promyelocytic leukemia cell differentiation is transcriptionally controlled.
    Bastie JN, Balitrand N, Guillemot I, Chomienne C, Delva L.
    Exp Cell Res; 2005 Nov 01; 310(2):319-30. PubMed ID: 16181625
    [Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. Phenotypic reversion in acute promyelocytic leukemia.
    Degos L.
    Nouv Rev Fr Hematol (1978); 1991 Nov 01; 33(6):511-5. PubMed ID: 1667950
    [Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. Differentiation therapy in acute promyelocytic leukemia: European experience.
    Degos L.
    J Cell Physiol; 1997 Nov 01; 173(2):285-7. PubMed ID: 9365538
    [Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 24.